Evidence map›Paper›PMID 27560652›Full record

ArticleGenetics and molecular biology

Evidence of ectopic recombination and a repeat-induced point (RIP) mutation in the genome of Sclerotinia sclerotiorum, the agent responsible for white mold.

Míriam Goldfarb, Mateus Ferreira Santana, Tânia Maria Fernandes Salomão, Marisa Vieira de Queiroz, Everaldo Gonçalves de Barros

Open access · goldAbstract read
In one paragraph

Article in Genetics and molecular biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Míriam GoldfarbLaboratório de Biologia Molecular de Plantas, Instituto de Biotecnologia Aplicada (BIOAGRO), Universidade Federal de Viçosa (UFV), 36570-000, Viçosa, MG, Brazil.
Mateus Ferreira SantanaLaboratório de Genética Molecular e de Microrganismo, Instituto de Biotecnologia Aplicada (BIOAGRO), Universidade Federal de Viçosa (UFV), 36570-000, Viçosa, MG, Brazil.
Tânia Maria Fernandes SalomãoLaboratório de Biologia Molecular de Insetos, Departamento de Biologia Geral, Universidade Federal de Viçosa (UFV), 36570-000, Viçosa, MG, Brazil.
Marisa Vieira de QueirozLaboratório de Genética Molecular e de Microrganismo, Instituto de Biotecnologia Aplicada (BIOAGRO), Universidade Federal de Viçosa (UFV), 36570-000, Viçosa, MG, Brazil.
Everaldo Gonçalves de BarrosLaboratório de Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, 70790-160, Brasília, DF, Brazil.
Universidade Federal de Viçosa · BRUniversidade Católica de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two retrotransposons from the superfamilies Copia and Gypsy named as Copia-LTR_SS and Gypsy-LTR_SS, respectively, were identified in the genomic bank of Sclerotinia sclerotiorum. These transposable elements (TEs) contained direct and preserved long terminal repeats (LTR). Domains related to codified regions for gag protein, integrase, reverse transcriptase and RNAse H were identified in Copia-LTR_SS, whereas in Gypsy-LTR_SS only domains for gag, reverse transcriptase and RNAse H were found. The abundance of identified LTR-Solo suggested possible genetic recombination events in the S. sclerotiorum genome. Furthermore, alignment of the sequences for LTR elements from each superfamily suggested the presence of a RIP (repeat-induced point mutation) silencing mechanism that may directly affect the evolution of this species.

Identifiers

PMID27560652
PMCPMC5004834
OpenAlexW2471474248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.